1A9bnbK
1A9bnbK
1A9bnbK
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
***<br />
INVESTING TOWARDS UNIVERSAL COVERAGE AGAINST NTDS − CHAPTER 2<br />
39<br />
2.7 Moving forward with country programmes<br />
In summary, the investment targeted by this report is about US$ 750 million on average<br />
per year during the period 2015–2020, not counting investments in vector control. This<br />
target represents an increase of about 130% over (more than double) the benchmark cost<br />
of interventions delivered in 2012, based on reported coverage data. Fig. 2.9 gives a sense of<br />
the magnitude of the scale-up required to 2020. If targets are met by 2020, investments in<br />
preventive chemotherapy and treatment and care may decrease to about US$ 460 million on<br />
average per year during 2021–2030.<br />
The Uniting to Combat NTDs coalition has reported that foreign aid in support of the<br />
London Declaration amounted to about US$ 300 million in 2014, not counting vector<br />
control (34). Commitments for the period 2015–2020 are currently projected at less than<br />
US$ 200 million per year. Some aid is destined for regional or global coordination, making<br />
direct comparison with the investment targets difficult. Nonetheless, Fig. 2.9 suggests that<br />
even if aid remains at 2014 levels until 2020 and all of it goes to countries, most of the<br />
investment will still have to come from other sources, increasingly from within endemic<br />
countries.<br />
Fig. 2.9 Foreign aid (2012–2014) and investment targets under the<br />
Roadmap (to 2020) and universal coverage against NTDs<br />
(to 2030), excluding vector control<br />
Constant US$ millions<br />
750<br />
500<br />
250<br />
●<br />
Investment targets<br />
Investment targets for low- and lower-middle-income countries<br />
Additional investments<br />
targeted to 2020<br />
Foreign aid (if 2014 levels maintained)<br />
0<br />
2012<br />
2015<br />
2020<br />
Year<br />
2025<br />
2030<br />
Notes: Foreign aid is reported by the Uniting to Combat NTDs coalition; it excludes the cost of medicines donated<br />
by the pharmaceutical industry and vector control. Two investment targets are presented: one for all endemic<br />
countries, the other for all countries excluding upper-middle-income countries where programmes are expected to<br />
be almost fully funded from domestic sources. The dot in 2012 is based on reported coverage numbers multiplied by<br />
unit cost benchmarks; it can be thought of as a benchmark for expenditures in 2012. All numbers expressed in US$<br />
are constant (real) US$, adjusted to reflect purchasing power in the United States of America in 2015.